253 related articles for article (PubMed ID: 29200949)
1. Over-expression of Activated Signal Transducer and Activator of Transcription 3 Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.
Li WM; Huang CN; Lee YC; Chen SH; Lin HH; Wu WJ; Li CC; Yeh HC; Chang LL; Hsu WC; Ke HL
Int J Med Sci; 2017; 14(13):1360-1367. PubMed ID: 29200949
[No Abstract] [Full Text] [Related]
2. STAT3 expression is a prognostic marker in upper urinary tract urothelial carcinoma.
Matsuzaki K; Fujita K; Hayashi Y; Matsushita M; Nojima S; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Uemura M; Imamura R; Yamaguchi S; Fushimi H; Miyamoto H; Morii E; Nonomura N
PLoS One; 2018; 13(8):e0201256. PubMed ID: 30091994
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
4. GPX2 underexpression indicates poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder.
Chang IW; Lin VC; Hung CH; Wang HP; Lin YY; Wu WJ; Huang CN; Li CC; Li WM; Wu JY; Li CF
World J Urol; 2015 Nov; 33(11):1777-89. PubMed ID: 25813210
[TBL] [Abstract][Full Text] [Related]
5. Endoglin expression in upper urinary tract urothelial carcinoma is associated with intravesical recurrence after radical nephroureterectomy.
Fujita K; Ujike T; Nagahara A; Uemura M; Tanigawa G; Shimazu K; Fushimi H; Yamaguchi S; Nonomura N
Int J Urol; 2015 May; 22(5):463-7. PubMed ID: 25631522
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of p21-activated kinase 1 expression level in patients with upper urinary tract urothelial carcinoma.
Kuroda K; Asakuma J; Asano T; Horiguchi A; Isono M; Tsujita Y; Sato A; Seguchi K; Ito K; Asano T
Jpn J Clin Oncol; 2015 Jan; 45(1):103-10. PubMed ID: 25324479
[TBL] [Abstract][Full Text] [Related]
7. Variant isoforms of CD44 expression in upper tract urothelial cancer as a predictive marker for recurrence and mortality.
Hagiwara M; Kikuchi E; Kosaka T; Mikami S; Saya H; Oya M
Urol Oncol; 2016 Aug; 34(8):337.e19-26. PubMed ID: 27133224
[TBL] [Abstract][Full Text] [Related]
8. Survivin is not an independent prognostic factor for patients with upper tract urothelial carcinoma: a multi-institutional study.
Mathieu R; Klatte T; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Bensalah K; Lotan Y; Rink M; Kluth LA; Scherr DS; Robinson BD; Shariat SF
Urol Oncol; 2015 Nov; 33(11):495.e15-22. PubMed ID: 26228160
[TBL] [Abstract][Full Text] [Related]
9. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
[TBL] [Abstract][Full Text] [Related]
10. PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
Yeh HC; Li CC; Huang CN; Hour TC; Yeh BW; Li WM; Liang PI; Chang LL; Li CF; Wu WJ
J Urol; 2015 Nov; 194(5):1449-55. PubMed ID: 26070892
[TBL] [Abstract][Full Text] [Related]
11. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma.
Miyazaki Y; Kosaka T; Mikami S; Kikuchi E; Tanaka N; Maeda T; Ishida M; Miyajima A; Nakagawa K; Okada Y; Sato Y; Oya M
Clin Cancer Res; 2012 Aug; 18(15):4145-53. PubMed ID: 22675166
[TBL] [Abstract][Full Text] [Related]
13. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
Kosaka T; Kikuchi E; Mikami S; Miyajima A; Shirotake S; Ishida M; Okada Y; Oya M
Clin Cancer Res; 2010 Dec; 16(23):5814-23. PubMed ID: 20947514
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and predictive value of epigenetic biomarkers and clinical factors in upper tract urothelial carcinoma.
Xiong G; Liu J; Tang Q; Fan Y; Fang D; Yang K; Xie F; Zhang M; Zhang L; Liu L; Zhang C; Yao L; Yang L; Ci W; Zhao W; Gong Y; He Q; Gong K; He Z; Wang G; Li X; Guo Y; Zhou L
Epigenomics; 2015 Aug; 7(5):733-44. PubMed ID: 25912368
[TBL] [Abstract][Full Text] [Related]
15. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Fan B; Hu B; Yuan Q; Wen S; Liu T; Bai S; Qi X; Wang X; Yang D; Sun X; Song X
Tumour Biol; 2017 Jul; 39(7):1010428317710822. PubMed ID: 28714362
[TBL] [Abstract][Full Text] [Related]
17. MCM10 overexpression implicates adverse prognosis in urothelial carcinoma.
Li WM; Huang CN; Ke HL; Li CC; Wei YC; Yeh HC; Chang LL; Huang CH; Liang PI; Yeh BW; Chan TC; Li CF; Wu WJ
Oncotarget; 2016 Nov; 7(47):77777-77792. PubMed ID: 27780919
[TBL] [Abstract][Full Text] [Related]
18. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of cytokeratin (CK) 5/6, CD44 and CK20 as prognostic biomarkers of non-muscle-invasive papillary upper tract urothelial carcinoma.
Jung M; Kim B; Moon KC
Histopathology; 2019 Feb; 74(3):483-493. PubMed ID: 30286252
[TBL] [Abstract][Full Text] [Related]
20. High Transaldolase 1 expression predicts poor survival of patients with upper tract urothelial carcinoma.
Wu YR; Lee YC; Li WM; Hsu WC; Lin HH; Chang LL; Huang AM; Jhan JH; Wu WJ; Li CC; Lee HY; Yeh HC; Ke HL
Pathol Int; 2021 Jul; 71(7):463-470. PubMed ID: 33848380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
